<SEC-DOCUMENT>9999999997-21-000691-index.html : 20210318
<SEC-HEADER>9999999997-21-000691.hdr.sgml : 20210318
<ACCEPTANCE-DATETIME>20210216153746
ACCESSION NUMBER:		9999999997-21-000691
CONFORMED SUBMISSION TYPE:	SEC STAFF LETTER
CATEGORY:             	REDACTED EXHIBIT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210218
ACTION DATE:               	20210218
RECEIVED DATE:           	20210216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CASI Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0000895051
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				581959440
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SEC STAFF LETTER

	BUSINESS ADDRESS:	
		STREET 1:		9620 MEDICAL CENTER DR
		STREET 2:		STE 300
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		240-864-2600

	MAIL ADDRESS:	
		STREET 1:		9620 MEDICAL CENTER DR
		STREET 2:		STE 300
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ENTREMED INC
		DATE OF NAME CHANGE:	19960415
</SEC-HEADER>
<DOCUMENT>
<TYPE>REDACTED EXHIBIT
<SEQUENCE>1
<FILENAME>filename1.pdf
<TEXT>
Document 1 - file: filename1.pdf

</DOCUMENT>
</SEC-DOCUMENT>